Diabetic Eye Disease

Growth factor shown to protect the retina in early stage diabetes

Growth factor shown to protect the retina in early stage diabetes

February 3, 2017

New research findings may lead to development of new therapies to delay or prevent the development of diabetic eye disease.

Boston, Mass. — Researchers from the Schepens Eye Research Institute of Massachusetts Eye and Ear have shown that a slight increase in transforming growth factor beta (TGF-β), which is present in preclinical animal models with diabetic eye disease, protects retinal blood vessels from damage that commonly occurs in the early stages of the disease (known as diabetic retinopathy). Their findings, 

Read more about Growth factor shown to protect the retina in early stage diabetes
Researchers identify candidate biomarker of accelerated onset diabetic retinopathy

Researchers identify candidate biomarker of accelerated onset diabetic retinopathy

April 1, 2016

 

Mass. Eye and Ear researchers describe, for the first time, an association between a defective myogenic response of blood vessels in the retina and early, accelerated development of retinopathy in patients with type 1 diabetes. The findings may lead to the development of targeted therapies to delay or prevent the development of diabetic retinopathy in this population.

(BOSTON) – Researchers from Massachusetts Eye and Ear and

Read more about Researchers identify candidate biomarker of accelerated onset diabetic retinopathy
Lloyd Paul Aiello

Comparing Diabetic Macular Edema Treatments

February 19, 2015

Results of the DRCR.net Protocol T Study 

In the first clinical trial directly comparing three drugs most commonly used to treat diabetic macular edema, researchers found all were effective in improving vision and preventing vision loss. However, one drug, aflibercept, provided greater improvement for people with more severe vision loss when treatment was initiated. The trial was conducted by the

Read more about Comparing Diabetic Macular Edema Treatments